Castle supporting series of initiatives to raise awareness of skin cancer

Castle Biosciences (CSTL) is recognizing Skin Cancer Awareness Month this May by supporting a series of initiatives designed to raise awareness, educate patients and families and empower those impacted by skin cancer. “At Castle, our mission is rooted in delivering clinically actionable information to patients and their clinical care teams – and that begins with awareness and education,” said Derek Maetzold, president and chief executive officer of Castle Biosciences. “By supporting organizations like IMPACT Melanoma and sharing real patient stories like Leah’s, we aim to drive conversations around early detection and personalized risk assessment in an effort to help improve patient outcomes.”